Biosimilar, biobetter and next generation therapeutic antibodies

MAbs. Mar-Apr 2011;3(2):107-10. doi: 10.4161/mabs.3.2.14785. Epub 2011 Mar 1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Biological Products / classification*
  • Biological Products / therapeutic use*
  • Drug Approval / legislation & jurisprudence
  • Drugs, Generic / classification*
  • Drugs, Generic / therapeutic use*
  • European Union
  • Humans
  • Mice
  • Protein Engineering
  • Therapeutic Equivalency
  • United States
  • United States Food and Drug Administration

Substances

  • Biological Products
  • Drugs, Generic